Who we are
Powered by pioneers in liquid biopsy
Haystack Oncology is based on over 20 years of liquid biopsy technology and clinical development led by the scientists specialized in cancer genomics who first envisioned non-invasive cancer screening, MRD detection, and advanced disease therapy monitoring. Their discoveries have positively affected millions of lives, and companies that employ their technology have generated billions of dollars in enterprise value.
Clinical Scientific Advisors
Haystack Oncology’s clinical advisory board brings a diversity of thought leadership among oncology experts, and is foundational to our mission of providing better MRD testing for better patient outcomes.
News & Events
Find out what's happening at Haystack Oncology and stay up-to-date with industry news.